Assignee
FOREST LAB HOLDINGS LTD
BM·20 granted patents·51 pending applications·144 citations·filing 2004–2015
Top patents by PatentIndex Score
71 records- 0194US9062053B2Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-Diazabicyclo[3,2,1]octane-2-carboxamide sodium saltFOREST LAB HOLDINGS LTD·Filed 2014·Granted Jun 23, 2015·15 cites·9 claims
- 0294US8835455B2Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium saltFOREST LAB HOLDINGS LTD·Filed 2013·Granted Sep 16, 2014·15 cites·10 claims
- 0392US8039009B2Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2005·Granted Oct 18, 2011·61 cites·23 claims
- 0488US7829569B2Solvate and crystalline forms of carbamoyl-cyclohexane derivativesFOREST LAB HOLDINGS LTD·Filed 2008·Granted Nov 9, 2010·15 cites·9 claims
- 0584US7456224B2Method for treating autismFOREST LAB HOLDINGS LTD·Filed 2004·Granted Nov 25, 2008·18 cites·4 claims
- 0681US8815870B24-(2-(6-substituted-hexylidene) hydrazinyl)benzonitrile and preparation thereofFOREST LAB HOLDINGS LTD·Filed 2013·Granted Aug 26, 2014·2 cites·13 claims
- 0781US7838552B2Compositions comprising nebivololFOREST LAB HOLDINGS LTD·Filed 2005·Granted Nov 23, 2010·3 cites·12 claims
- 0877US7803838B2Compositions comprising nebivololFOREST LAB HOLDINGS LTD·Filed 2005·Granted Sep 28, 2010·1 cites·12 claims
- 0975US9283261B2Linaclotide compositionsFOREST LAB HOLDINGS LTD·Filed 2014·Granted Mar 15, 2016·1 cites·22 claims
- 1075US9221821B2Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compoundsFOREST LAB HOLDINGS LTD·Filed 2013·Granted Dec 29, 2015·2 cites·35 claims
- 1172US7842696B2Piperazine derivatives as inhibitors of stearoyl-CoA desaturaseFOREST LAB HOLDINGS LTD·Filed 2008·Granted Nov 30, 2010·3 cites·53 claims
- 1272US7501438B2Pyridoimidazole derivativesFOREST LAB HOLDINGS LTD·Filed 2007·Granted Mar 10, 2009·1 cites·24 claims
- 1371US8044041B2Phthalazine derivatives as inhibitors of protein kinaseFOREST LAB HOLDINGS LTD·Filed 2007·Granted Oct 25, 2011·1 cites·32 claims
- 1471US7897595B2Pyridoazepine derivativesFOREST LAB HOLDINGS LTD·Filed 2007·Granted Mar 1, 2011·1 cites·29 claims
- 1569US8633241B2Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivololFOREST LAB HOLDINGS LTD·Filed 2013·Granted Jan 21, 2014·2 cites·32 claims
- 1669US7569605B2Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropionFOREST LAB HOLDINGS LTD·Filed 2006·Granted Aug 4, 2009·2 cites·9 claims
- 1769US2009247644A1Memantine formulationsFOREST LAB HOLDINGS LTD·Filed 2009·Application pending·0 cites
- 1868US9259403B2Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamideFOREST LAB HOLDINGS LTD·Filed 2014·Granted Feb 16, 2016·0 cites·6 claims
- 1968US8039463B2Piperazine derivatives as inhibitors of stearoyl-CoA desaturaseFOREST LAB HOLDINGS LTD·Filed 2009·Granted Oct 18, 2011·1 cites·10 claims
- 2068US2010081723A1Memantine For The Treatment Of Childhood Behavioral DisordersFOREST LAB HOLDINGS LTD·Filed 2009·Application pending·0 cites
- 2168US2009275597A1Methods of treating cns disordersFOREST LAB HOLDINGS LTD·Filed 2009·Application pending·0 cites
- 2266US2009048348A1Method for treating autismFOREST LAB HOLDINGS LTD·Filed 2008·Application pending·0 cites
- 2365US2013302430A1Modified and immediate release formulations of memantineFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 2465US2009143593A1Synthesis of heterocyclic compoundsFOREST LAB HOLDINGS LTD·Filed 2009·Application pending·0 cites
- 2563US7511150B2Synthesis of heterocyclic compoundsFOREST LAB HOLDINGS LTD·Filed 2007·Granted Mar 31, 2009·0 cites·18 claims
- 2662US2014018307A1Linaclotide compositionsFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 2762US2013210919A1Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamideFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 2861US2014213659A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 2961US2013253063A1Stable dosage forms of levomilnacipranFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 3061US2009082326A1Soluble dosage forms containing cephem derivatives suitable for parenteral administrationFOREST LAB HOLDINGS LTD·Filed 2008·Application pending·0 cites
- 3161US2013273169A1Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral AdministrationFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 3261US2015065582A1Orally Dissolving Formulations of MemantineFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 3360US2009036468A1Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligandsFOREST LAB HOLDINGS LTD·Filed 2008·Application pending·0 cites
- 3460US2009192315A1Synthesis of heterocyclic compoundsFOREST LAB HOLDINGS LTD·Filed 2008·Application pending·0 cites
- 3560US2013310460A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 3660US2008008743A1Orally Dissolving Formulations of MemantineFOREST LAB HOLDINGS LTD·Filed 2007·Application pending·0 cites
- 3760US2015258042A1Modified and immediate release formulations of memantineFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 3859US2014348932A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 3958US2013012593A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2012·Application pending·0 cites
- 4057US2014057954A1Chemical compositionFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 4157US2013011474A1Modified and immediate release formulations of memantineFOREST LAB HOLDINGS LTD·Filed 2012·Application pending·0 cites
- 4255US2011245254A1Heterocyclic compounds as inhibitors of beta-lactamasesFOREST LAB HOLDINGS LTD·Filed 2011·Application pending·0 cites
- 4355US2015148424A1Stable dosage forms of levomilnacipranFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 4455US2015157575A1Pharmaceutical Formulations Comprising VilazodoneFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 4554US2015031632A1Orally Disintegrating Compositions of LinaclotideFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 4654US2015258031A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 4754US2015132382A1Compositions and methods of treatment comprising fosfomycin disodiumFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 4853US2010048726A1Memantine For The Treatment Of Mild And Mild To Moderate Alzheimer's DiseaseFOREST LAB HOLDINGS LTD·Filed 2009·Application pending·0 cites
- 4953US2015148427A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 5053US2013012712A1Method for preparing disubstituted piperidine and intermediatesFOREST LAB HOLDINGS LTD·Filed 2012·Application pending·0 cites
Showing the top 50 of 71 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →